CN1050051C - "Dianjiankang" - a Chinese proprietary medicine for treatment of epilepsy - Google Patents
"Dianjiankang" - a Chinese proprietary medicine for treatment of epilepsy Download PDFInfo
- Publication number
- CN1050051C CN1050051C CN94117502A CN94117502A CN1050051C CN 1050051 C CN1050051 C CN 1050051C CN 94117502 A CN94117502 A CN 94117502A CN 94117502 A CN94117502 A CN 94117502A CN 1050051 C CN1050051 C CN 1050051C
- Authority
- CN
- China
- Prior art keywords
- chinese patent
- patent medicine
- epilepsy
- treating
- medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a Chinese patent medicine for treating epilepsy. Epilepsy is a stubborn disease which is hard to radically treat, and the existing effects of traditional and western medicines for treating epilepsy are not ideal. The Chinese patent medicine is based on the treating principle of treating epilepsy, extinguishing wind, eliminating phlegm for resuscitation, clearing heart fire and activating blood circulation to dissipate blood stasis. The oral Chinese patent medicine is prepared from centipede, scorpion, stiff silkorm, earthworm, red sage root, safflower, gastrodia tuber, grassleaf sweetflag rhizome, bile arisaema, alum and calculus bovis. The prescription can not only consider the control of acute phase symptoms of epilepsy, but also have the function of strengthening treating effects, and the purpose of treating both manifestation and root causes of diseases can be obtained. The clinical effective rate is 91%, and the Chinese patent medicine has the advantages of small toxic or side effects, safe and reliable performance and low price, and the Chinese patent medicine is easy to receive by patients.
Description
The invention belongs to a kind of Chinese patent medicine for the treatment of epileptics.
Epilepsy is neural a kind of commonly encountered diseases, frequently-occurring disease, because its cause of disease complexity, outbreak repeatedly is difficult to radical cure, is one of difficult treatment kind so be known as.Existing this sick Chinese medicine and western medicine effect of treatment is all not ideal enough.
The present invention aims to provide the Chinese patent medicine of a kind of curative effect height, toxic and side effects is little, price is low treatment epileptics.
For achieving the above object, Chinese patent medicine of the present invention adopts following Chinese medicine raw materials by weight proportion (a is Unit Weight part):
Scolopendra 8-12a Scorpio 8-12a Bombyx Batryticatus 8-12a Pheretima 8-12a
Radix Salviae Miltiorrhizae 18-22a Flos Carthami 10-14a Rhizoma Gastrodiae 8-12a Rhizoma Acori Graminei 8-12a
Arisaema Cum Bile 8-12a Alumen 4-8a Calculus Bovis 4-8a
Above-mentioned materials of weight proportions is made the oral Chinese patent medicine of various dosage forms with traditional method.
The Therapeutic Principle of this medicine is: decide that epilepsy relieves dizziness, high fever, infantile convulsions, epilepsy, etc., eliminates phlegm for resuscitation, clearing heart fire and helping with blood circulation promoting and blood stasis dispelling.
Radix Salviae Miltiorrhizae in the said medicine, Flos Carthami master blood circulation promoting and blood stasis dispelling improve brain blood circulation, increase oxygen supply, can make traumatic epilepsy improve symptom.Scorpio, Scolopendra master relieving spasm by subduing liver-wind, activating collaterals and eliminating stagnation has the antagonism function to various convulsions.Bombyx Batryticatus master wind-heat dissipating, the endogenous wind stopping relieving convulsion has block nerves joint and calmness and decides the epilepsy effect.Pheretima master clearing away heat and relieving the wind syndrome, collateral dredging are only taken out, and reliable calm anticonvulsant action is arranged, and the type of intenseness of phlegm-fire epilepsy is had ideal effect.Rhizoma Gastrodiae and Scorpio, Scolopendra compatibility can be strengthened the spasmolytic function.Arisaema Cum Bile master clearing and dissipating phlegm-heat, dispelling wind and relieving convulsion.Rhizoma Acori Graminei have eliminate phlegm for resuscitation, fragrance goes turbid function, and nervus centralis is had calmness and anticonvulsant action.Alumen heat clearing away expectorant is the key medicine of treatment wind-phlegm epilepsy.Calculus Bovis master clearing heart fire, waking up the patient from unconsciousness by dissipating phlegm.
The treatment standard of formulating by in November, 85 " first national epilepsy academic conference of Chinese Medical Association " is as follows to 1000 routine epileptics clinical observation statistical result after 2 course of therapy:
Press epilepsy situation statistics:
Press epilepsy type statistics curative effect:
| Recovery from illness | Produce effects | Effectively | Invalid | Amount to | |
| Grand mal | 574 | 153 | 46 | 63 | 836 examples |
| Petit mal | 108 | 13 | 22 | 21 | 164 examples |
| Subtotal | 682 | 166 | 68 | 84 | 1000 |
| Recovery from illness | Produce effects | Effectively | Invalid | Amount to | |
| Constitutional | 529 | 112 | 38 | 59 | 738 |
| Secondary cases | 153 | 54 | 30 | 25 | 262 |
| Subtotal | 682 | 166 | 68 | 84 | 1000 |
Can get from above-mentioned statistics: 682 examples of fully recovering (68.2%) produce effects 166 examples (16.6%), effective 68 examples (6.8%), invalid 84 examples (8.4%), total effective rate is 91.6%, does not see toxic side effect.
This medicine has been used modern Chinese medicine drug effect centering pharmaceutically active ingredient has had the new results (for example the d-asaricin that extracts in the Rhizoma Acori Graminei volatile oil promptly has obvious antiepileptic action) of further understanding to carry out prescription, and whole prescription had both been considered the acute stage symptom control of epilepsy, the function of consolidating curative effect is arranged again, reach the purpose for the treatment of both the principal and secondary aspects of a disease, therefore obtain outstanding curative effect, our toxic and side effects is little, safe and reliable simultaneously, price is low, and the patient is easy to accept.
Embodiment 1
Present embodiment adopts following Chinese medicine raw materials by weight proportion:
Scolopendra 10g Scorpio 10g Bombyx Batryticatus 10g Pheretima 10g
Radix Salviae Miltiorrhizae 20g Flos Carthami 12g Rhizoma Gastrodiae 10g Rhizoma Acori Graminei 10g
Arisaema Cum Bile 10g Alumen 6g Calculus Bovis 6g
The brewing method of above-mentioned each raw material of Chinese medicine is:
Scolopendra: decaptitating truncates, and dries scalding.
Scorpio: adopt moxibustion therapy, it is placed in the pot make popular, put into Mel one companion of dissolving again and fry to doing
Take out, sieve above baking at ferrum and do.
Bombyx Batryticatus: clean with clear water earlier and take out, join Radix Glycyrrhizae 60 grams with the per kilogram Bombyx Batryticatus again, add 1 kilogram in water, put
Go into to boil 2 hours in the pot, take out Bombyx Batryticatus and filter, dry back sieve dedust bits, get system Testa Tritici and go into pot
, put on the slow fire and make popular, put into this product again and stir, cooling to the faint yellow bran that goes.
Pheretima: use the stir-fry method.Get system Testa Tritici and put in the pot and make popular, add Pheretima again, stir to Pheretima with slow fire
End when being yellow, take out, sieve removes Testa Tritici, cooling.
Radix Salviae Miltiorrhizae: dry.
Flos Carthami: with the grey to the greatest extent bits of dusting cover sieve.
Rhizoma Gastrodiae: get Rhizoma Gastrodiae slice and go into pot and make popular, per 30 gram Rhizoma Gastrodiaes are with Rhizoma Zingiberis Recenss 10 gram, with Rhizoma Zingiberis Recens mash add water a little
Remove slag, spray Rhizoma Gastrodiae, stir evenly with Sucus Zingberis, fry do to water till, fry with slow fire, turn at any time
Moving, must not parching to brown.
Rhizoma Acori Graminei: use the stir-fry method, get the Rhizoma Acori Graminei sheet and put into pot clean stir-fry till be yellow, cooling.
Arisaema Cum Bile: salt down with the bright sail of Rhizoma Zingiberis Recens again after soaking with clear water repeatedly and mix elutriation, till not having a numb astringent taste,
To subtract its toxicity.
To stir evenly through respectively distinguish the flavor of raw material of Chinese medicine and Alumen, the equal pulverization of Calculus Bovis that said method was handled, promptly make this one-tenth powdered medicine.
Instructions about how to take medicine: day clothes twice, each 5 grams, 30 days is a course of treatment.
Embodiment 2
This example adopts following Chinese medicine raw materials by weight proportion:
Scolopendra 8g Scorpio 8g Bombyx Batryticatus 8g Pheretima 8g
Radix Salviae Miltiorrhizae 18g Flos Carthami 10g Rhizoma Gastrodiae 8g Rhizoma Acori Graminei 8g
Arisaema Cum Bile 8g Alumen 4g Calculus Bovis 4g
Embodiment 3
This example adopts following Chinese medicine raw materials by weight proportion:
Scolopendra 12g Scorpio 12g Bombyx Batryticatus 12g Pheretima 12g
Radix Salviae Miltiorrhizae 22g Flos Carthami 14g Rhizoma Gastrodiae 12g Rhizoma Acori Graminei 12g
Arisaema Cum Bile 12g Alumen 8g Calculus Bovis 8g
Claims (2)
1, the Chinese patent medicine of treatment epileptics is characterized in that this Chinese patent medicine adopts following Chinese medicine raw materials by weight proportion:
Scolopendra 8-12a Scorpio 8-12a Bombyx Batryticatus 8-12a Pheretima 8-12a
Radix Salviae Miltiorrhizae 18-22a Flos Carthami 10-14a Rhizoma Gastrodiae 8-12a Rhizoma Acori Graminei 8-12a
Arisaema Cum Bile 8-12a Alumen 4-8a Calculus Bovis 4-8a
Wherein a is Unit Weight part;
The raw material of above-mentioned weight ratio is made the oral Chinese patent medicine of various dosage forms with traditional method.
2. Chinese patent medicine according to claim 1 is characterized in that: this Chinese patent medicine adopts following raw material of Chinese medicine and weight proportion:
Scolopendra 10a Scorpio 10a Bombyx Batryticatus 10a Pheretima 10a
Radix Salviae Miltiorrhizae 20a Flos Carthami 12a Rhizoma Gastrodiae 10a Rhizoma Acori Graminei 10a
Arisaema Cum Bile 10a Alumen 6a Calculus Bovis 6a
Wherein a is Unit Weight part, and above-mentioned Chinese medicine raw materials by weight proportion is made powder preparation formulation.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN94117502A CN1050051C (en) | 1994-10-24 | 1994-10-24 | "Dianjiankang" - a Chinese proprietary medicine for treatment of epilepsy |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN94117502A CN1050051C (en) | 1994-10-24 | 1994-10-24 | "Dianjiankang" - a Chinese proprietary medicine for treatment of epilepsy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1117865A CN1117865A (en) | 1996-03-06 |
| CN1050051C true CN1050051C (en) | 2000-03-08 |
Family
ID=5038390
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN94117502A Expired - Fee Related CN1050051C (en) | 1994-10-24 | 1994-10-24 | "Dianjiankang" - a Chinese proprietary medicine for treatment of epilepsy |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1050051C (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101293084B (en) * | 2008-05-08 | 2011-06-15 | 张晓艳 | Shock-resistant spasm-relieving traditional Chinese medicine preparation |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1067567C (en) * | 1997-08-27 | 2001-06-27 | 黄朝明 | Chinese traditional medicine for treating epilepsy |
| CN101816751B (en) * | 2010-04-28 | 2011-06-01 | 史建钢 | Medicament for treating epilepsy and tourette syndrome and preparation method thereof |
| CN103446459B (en) * | 2013-09-11 | 2015-01-21 | 上海民生志远健康管理科技发展有限公司 | Traditional Chinese medicine pill for treating intracranial tumor-induced epilepsy |
| CN105194228A (en) * | 2015-11-12 | 2015-12-30 | 贵州盛世保康茶开发有限公司 | Miao medicine for treating epilepsy |
| CN106236781A (en) * | 2016-08-22 | 2016-12-21 | 兰恒才 | A kind of medicine treating convulsions and preparation method thereof |
| CN114042138A (en) * | 2021-12-16 | 2022-02-15 | 武星媛 | Medicine for treating epilepsy |
-
1994
- 1994-10-24 CN CN94117502A patent/CN1050051C/en not_active Expired - Fee Related
Non-Patent Citations (3)
| Title |
|---|
| 《中西结合杂志》1984年第4卷第8期 1984.8.1 陈雅民，抗癫痫中药作用机制与临床应用 * |
| 《新中医》1984年第11期 1984.11.1 李贵生，活血化淤为主治疗癫痫病 * |
| 《新中医》1984年第11期 1984.11.1 李贵生，活血化淤为主治疗癫痫病;《中西结合杂志》1984年第4卷第8期 1984.8.1 陈雅民，抗癫痫中药作用机制与临床应用 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101293084B (en) * | 2008-05-08 | 2011-06-15 | 张晓艳 | Shock-resistant spasm-relieving traditional Chinese medicine preparation |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1117865A (en) | 1996-03-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101028507A (en) | Chinese-medicinal composition for treating asthma | |
| CN1240416C (en) | Medicine for curing hypertension and its preparation method | |
| CN1050051C (en) | "Dianjiankang" - a Chinese proprietary medicine for treatment of epilepsy | |
| CN1088369C (en) | Moxibustion liquid --moxibustion fixing paste and its preparation method and use method | |
| CN1165686A (en) | Medicinal cream for treating sore and its prepn. method | |
| CN1059105C (en) | Bi Syndrome curing medicine | |
| CN1160108C (en) | Medicine for treating cholecystitis and its preparing process | |
| CN1108810C (en) | Medicine for treating psoriasis and preparing process thereof | |
| CN1261140C (en) | Medicine for treating burns and scalds | |
| CN1196254A (en) | Pill for treating arthritis and its compounding method | |
| CN1513519A (en) | Heart quieting and orifice opening capsule and its preparation | |
| CN1582989A (en) | Medicine for hyperplasia of mammary glands and its preparation | |
| CN1087621C (en) | Ointment for treating burn and scald | |
| CN1045892C (en) | Chinese medicine Guanxintong for preventing and curing coronary heart disease and angina pectoris, and producing process thereof | |
| CN1285345C (en) | Compound cactsu antivirus preparation | |
| CN1245197C (en) | Chinese medicine preparation for treating coronary heart disease and viral myocarditis | |
| CN1132603C (en) | Compound Wuduqing capsule of blister beetle | |
| CN106962997A (en) | A kind of preparation method of new type of health wrister | |
| CN1282478C (en) | Traditional Chinese medicine preparation for treating uremia and its preparation method | |
| CN1943669A (en) | The Chinese traditional medicinal preparation for treatment of calculus | |
| CN1201769C (en) | Medicine for treating diabetes, nephropathy | |
| CN101332261A (en) | External medicine for treating furunculosis | |
| CN1316268A (en) | Qufengbaidu pill for treating skin itchings | |
| CN105031304A (en) | Traditional Chinese medicine for treating prosopalgia and preparation method thereof | |
| CN1088801A (en) | Chinese patent medicine Jinguanpian tablets and the method for making thereof of treatment insensitive impediment, particularly RA and AS |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |